TrueBlue (TBI) Misses Q3 EPS by 5c, Q4 Guidance Falls Short
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $8.17 +21.04%
EPS Growth %: +142.9%
Financial Fact:
Income tax expense: 3.46M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +142.9%
Financial Fact:
Income tax expense: 3.46M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q3 EPS of $0.70, $0.05 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $697.1 million versus the consensus estimate of $715.69 million.
GUIDANCE:
TrueBlue sees Q4 2016 EPS of $0.54-$0.59, versus the consensus of $0.69. TrueBlue sees Q4 2016 revenue of $670-686 million, versus the consensus of $776.5 million.
For earnings history and earnings-related data on TrueBlue (TBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AbbVie updates 2026 EPS guidance after $291M IPR&D charge
- RxSight cuts 2026 sales outlook, citing competitive headwinds
- Morgan Stanley Resumes American Eagle Outfitters (AEO) at Equalweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
